nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with relapsed or refractory non-small cell lung cancer
|
Sherman, Carol A. |
|
2004 |
45 |
3 |
p. 387-392 6 p. |
artikel |
2 |
Cavitating squamous cell lung carcinoma-distinct entity or not?
|
Pentheroudakis, G. |
|
2004 |
45 |
3 |
p. 349-355 7 p. |
artikel |
3 |
Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)
|
Ishii, Haruhiko |
|
2004 |
45 |
3 |
p. 325-337 13 p. |
artikel |
4 |
Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC)
|
Ferrigno, Domenico |
|
2004 |
45 |
3 |
p. 373-380 8 p. |
artikel |
5 |
Letter related to the article “Radiological examination for peripheral lung cancers and benign nodules less than 10 mm” Lung Cancer 2003;42:291–6
|
Sortini, D. |
|
2004 |
45 |
3 |
p. 393-394 2 p. |
artikel |
6 |
Lung cancer among women in France.
|
Grivaux, Michel |
|
2004 |
45 |
3 |
p. 279-287 9 p. |
artikel |
7 |
Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma
|
Bajard, A. |
|
2004 |
45 |
3 |
p. 317-323 7 p. |
artikel |
8 |
Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer
|
Reid, Tony |
|
2004 |
45 |
3 |
p. 381-386 6 p. |
artikel |
9 |
pre v: Contents
|
|
|
2004 |
45 |
3 |
p. v- 1 p. |
artikel |
10 |
pre vi: Contents continued
|
|
|
2004 |
45 |
3 |
p. vi- 1 p. |
artikel |
11 |
pre vii: Calendar of Events
|
|
|
2004 |
45 |
3 |
p. vii- 1 p. |
artikel |
12 |
Reply to the Editor
|
Ohtsuka, Takashi |
|
2004 |
45 |
3 |
p. 395-396 2 p. |
artikel |
13 |
Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung
|
Berge, Gisle |
|
2004 |
45 |
3 |
p. 289-297 9 p. |
artikel |
14 |
Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines
|
Bazhin, Alexandr V |
|
2004 |
45 |
3 |
p. 299-305 7 p. |
artikel |
15 |
Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein
|
Otsuka, Hiroshi |
|
2004 |
45 |
3 |
p. 307-316 10 p. |
artikel |
16 |
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy
|
Berghmans, T. |
|
2004 |
45 |
3 |
p. 339-348 10 p. |
artikel |
17 |
Targeted radiotherapy for small cell lung cancer using 90 Y ttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial
|
Pless, Miklos |
|
2004 |
45 |
3 |
p. 365-371 7 p. |
artikel |
18 |
What is early lung cancer?
|
Pasic, Arifa |
|
2004 |
45 |
3 |
p. 267-277 11 p. |
artikel |
19 |
15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer
|
Shargall, Yaron |
|
2004 |
45 |
3 |
p. 357-363 7 p. |
artikel |